PTC Therapeutics Inc. Stock
PTC Therapeutics Inc. Stock
PTC Therapeutics Inc. dominated the market today, gaining €1.20 (3.770%).
Currently there is a rather positive sentiment for PTC Therapeutics Inc. with 15 Buy predictions and 8 Sell predictions.
With a target price of 41 € there is a positive potential of 24.24% for PTC Therapeutics Inc. compared to the current price of 33.0 €.
Our community identified positive and negative aspects for PTC Therapeutics Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the PTC Therapeutics Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of PTC Therapeutics Inc. in the next few years
Pros
?
S********** s********
?
B****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of PTC Therapeutics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
PTC Therapeutics Inc. | 3.770% | -3.509% | 10.738% | -14.508% | 30.952% | 5.096% | -7.602% |
Ironwood Pharmaceuticals | -0.900% | 0.917% | -24.138% | -46.078% | -46.078% | -41.489% | - |
Novocure Ltd | -0.580% | -4.920% | 76.819% | -69.807% | 42.137% | -87.839% | - |
Iovance Biotherapeutics Inc. | -0.550% | -11.212% | -25.833% | 0.392% | 4.867% | -45.918% | - |
Comments
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $32.00. They now have a "sell" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Citigroup Inc. from $18.00 to $26.00. They now have a "sell" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at JPMorgan Chase & Co. from $43.00 to $53.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat